Wellington Shields Capital Management Holding in Conagra Brands (CAG) Cut by $372,900; Sigma Planning Position in Gilead Sciences (GILD) Decreased as Share Value Declined

February 13, 2018 - By Adrian Erickson

Sigma Planning Corp decreased its stake in Gilead Sciences Inc (GILD) by 24.9% based on its latest 2017Q3 regulatory filing with the SEC. Sigma Planning Corp sold 9,160 shares as the company’s stock declined 8.05% while stock markets rallied. The institutional investor held 27,631 shares of the health care company at the end of 2017Q3, valued at $2.24 million, down from 36,791 at the end of the previous reported quarter. Sigma Planning Corp who had been investing in Gilead Sciences Inc for a number of months, seems to be less bullish one the $103.98B market cap company. The stock decreased 0.68% or $0.541 during the last trading session, reaching $79.599. About 1.21 million shares traded. Gilead Sciences, Inc. (NASDAQ:GILD) has declined 21.80% since February 13, 2017 and is downtrending. It has underperformed by 38.50% the S&P500.

Wellington Shields Capital Management Llc decreased its stake in Conagra Brands Inc (CAG) by 10.33% based on its latest 2017Q3 regulatory filing with the SEC. Wellington Shields Capital Management Llc sold 11,300 shares as the company’s stock declined 4.77% while stock markets rallied. The institutional investor held 98,130 shares of the consumer non-durables company at the end of 2017Q3, valued at $3.31 million, down from 109,430 at the end of the previous reported quarter. Wellington Shields Capital Management Llc who had been investing in Conagra Brands Inc for a number of months, seems to be less bullish one the $14.15B market cap company. The stock decreased 1.09% or $0.39 during the last trading session, reaching $35.31. About 428,761 shares traded. Conagra Brands, Inc. (NYSE:CAG) has risen 8.39% since February 13, 2017 and is uptrending. It has underperformed by 8.31% the S&P500.

Investors sentiment increased to 0.99 in 2017 Q3. Its up 0.17, from 0.82 in 2017Q2. It increased, as 53 investors sold CAG shares while 197 reduced holdings. 66 funds opened positions while 181 raised stakes. 310.77 million shares or 1.88% less from 316.73 million shares in 2017Q2 were reported. 1,000 are owned by Cap Guardian Tru Co. Moreover, Advisory Svcs Ntwk Ltd Liability has 0.01% invested in Conagra Brands, Inc. (NYSE:CAG). State Of Wisconsin Board has 0.02% invested in Conagra Brands, Inc. (NYSE:CAG) for 152,556 shares. Hartford Investment reported 157,520 shares. Mercer Cap Advisers Inc has invested 0.01% of its portfolio in Conagra Brands, Inc. (NYSE:CAG). Eqis Capital Mgmt accumulated 25,321 shares. Bessemer Grp owns 1.05M shares or 0.14% of their US portfolio. J Goldman And Lp holds 0.03% of its portfolio in Conagra Brands, Inc. (NYSE:CAG) for 15,100 shares. Rothschild Invest Il owns 8,154 shares. Argyle Cap invested in 0.74% or 55,945 shares. Guyasuta Investment Advsr has invested 0.03% in Conagra Brands, Inc. (NYSE:CAG). Moreover, Nj State Employees Deferred Compensation Plan has 0.15% invested in Conagra Brands, Inc. (NYSE:CAG) for 25,000 shares. Finance Advisory reported 8,223 shares. Roosevelt Group Inc Inc holds 0.08% or 24,593 shares. Guggenheim Capital Lc holds 0.12% or 1.48M shares in its portfolio.

Since October 13, 2017, it had 0 insider purchases, and 2 sales for $5.47 million activity. $4.59M worth of Conagra Brands, Inc. (NYSE:CAG) was sold by Batcheler Colleen on Friday, October 13.

Among 14 analysts covering ConAgra Foods (NYSE:CAG), 9 have Buy rating, 0 Sell and 5 Hold. Therefore 64% are positive. ConAgra Foods had 46 analyst reports since September 16, 2015 according to SRatingsIntel. The firm has “Buy” rating given on Friday, July 28 by Jefferies. UBS initiated the shares of CAG in report on Monday, November 14 with “Neutral” rating. The rating was maintained by Jefferies with “Buy” on Thursday, July 6. Deutsche Bank maintained the shares of CAG in report on Friday, September 25 with “Hold” rating. The stock has “Hold” rating by Deutsche Bank on Friday, April 8. Stifel Nicolaus maintained the stock with “Hold” rating in Monday, July 24 report. The rating was maintained by RBC Capital Markets on Friday, September 29 with “Buy”. As per Tuesday, November 7, the company rating was maintained by RBC Capital Markets. UBS maintained Conagra Brands, Inc. (NYSE:CAG) rating on Friday, June 30. UBS has “Sell” rating and $3300 target. The firm has “Buy” rating by Morgan Stanley given on Friday, June 23.

Wellington Shields Capital Management Llc, which manages about $901.02M and $609.08M US Long portfolio, upped its stake in Under Armour Inc Class A (NYSE:UA) by 31,075 shares to 45,235 shares, valued at $745,000 in 2017Q3, according to the filing. It also increased its holding in Range Resources Corp. (NYSE:RRC) by 68,303 shares in the quarter, for a total of 87,805 shares, and has risen its stake in Accenture Ltd (NYSE:ACN).

Investors sentiment increased to 1.03 in Q3 2017. Its up 0.10, from 0.93 in 2017Q2. It is positive, as 96 investors sold GILD shares while 488 reduced holdings. 127 funds opened positions while 474 raised stakes. 957.62 million shares or 2.06% more from 938.32 million shares in 2017Q2 were reported. Macquarie Gru Limited owns 479,332 shares for 0.07% of their portfolio. Nj State Employees Deferred Compensation Plan owns 0.59% invested in Gilead Sciences, Inc. (NASDAQ:GILD) for 40,000 shares. Paradigm Advsrs Llc owns 8,723 shares. Plancorp Llc reported 0.4% in Gilead Sciences, Inc. (NASDAQ:GILD). Robeco Institutional Asset Bv invested 0.23% of its portfolio in Gilead Sciences, Inc. (NASDAQ:GILD). Gamco Et Al stated it has 0.01% in Gilead Sciences, Inc. (NASDAQ:GILD). Meritage Port Mgmt, Kansas-based fund reported 11,173 shares. Bennicas & owns 22,600 shares for 1.56% of their portfolio. Amp Cap Investors Ltd has invested 0.37% in Gilead Sciences, Inc. (NASDAQ:GILD). The Indiana-based Lynch Assocs In has invested 0.46% in Gilead Sciences, Inc. (NASDAQ:GILD). Parnassus Investments Ca reported 18.70 million shares. Savant Lc reported 0.11% stake. Yhb Inv Advsr owns 28,010 shares for 0.41% of their portfolio. Walter & Keenan Financial Consulting Mi Adv accumulated 6,800 shares or 0.25% of the stock. Montag A, Georgia-based fund reported 49,083 shares.

Since August 30, 2017, it had 0 insider purchases, and 13 insider sales for $51.09 million activity. MARTIN JOHN C sold $6.09M worth of stock or 73,333 shares. $8.02 million worth of Gilead Sciences, Inc. (NASDAQ:GILD) was sold by Meyers James R on Tuesday, January 16. 51,820 shares valued at $4.40 million were sold by Washington Robin L on Thursday, September 7.

Sigma Planning Corp, which manages about $1.21B US Long portfolio, upped its stake in Waste Mgmt Inc Del (NYSE:WM) by 8,860 shares to 33,317 shares, valued at $2.61M in 2017Q3, according to the filing. It also increased its holding in Ishares Tr (EMB) by 4,002 shares in the quarter, for a total of 47,135 shares, and has risen its stake in Ventas Inc (NYSE:VTR).

Among 30 analysts covering Gilead Sciences (NASDAQ:GILD), 21 have Buy rating, 0 Sell and 9 Hold. Therefore 70% are positive. Gilead Sciences had 124 analyst reports since July 29, 2015 according to SRatingsIntel. Mizuho maintained Gilead Sciences, Inc. (NASDAQ:GILD) rating on Monday, February 12. Mizuho has “Buy” rating and $95.0 target. Cowen & Co maintained Gilead Sciences, Inc. (NASDAQ:GILD) on Tuesday, July 25 with “Buy” rating. The rating was maintained by RBC Capital Markets with “Outperform” on Wednesday, July 29. Needham downgraded the stock to “Hold” rating in Tuesday, July 26 report. The firm has “Buy” rating given on Thursday, August 31 by William Blair. The rating was maintained by Mizuho on Monday, February 5 with “Buy”. The stock of Gilead Sciences, Inc. (NASDAQ:GILD) has “Buy” rating given on Monday, July 24 by J.P. Morgan. The stock has “Outperform” rating by RBC Capital Markets on Monday, October 3. The rating was initiated by Stifel Nicolaus on Monday, November 14 with “Buy”. As per Friday, January 26, the company rating was upgraded by Jefferies.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: